To investigate the relationship between SCD1, ACC and lipogenesis in cancer cell proliferation, we treated H460 cells with CP-640186, a specific inhibitor of ACC, at a concentration of 20 μM which inhibits more than 95% of enzyme activity [14]. Here, SCD is linked to cancer.